* The University of California at Berkeley completed its capital campaign in December, raising $1.44 billion and beating its $1.1 billion goal. The previous record for fundraising by a public university was $1.41 billion raised by the University of Michigan at Ann Arbor in a campaign that ended in 1997. UCLA is in the midst of a campaign to raise $1.6 billion by 2002.
* Gilbert Stuart’s “Lansdowne” portrait of George Washington will remain in the National Portrait Gallery of the Smithsonian Institution, thanks to a $30 million gift from the Donald W. Reynolds Foundation in Las Vegas, the Washington Business Journal reported March 12. For full story, go to the Washington Business Journal.
* The United Way of the Texas Gulf Coast in Houston raised a record-high $75 million for its 2000-01 campaign, posting the biggest single one-year increase — $5 million – in a decade.
* The Cystic Fibrosis Foundation will provide Altus Biologics Inc. with up to $25 million in grant funding, plus access to its Therapeutics Development Network, to speed development of a new drug to treat pancreatic insufficiency, which affects most people with cystic fibrosis, Drug Discovery Online reported March 9. For full story, go to Drug Discovery Online.
* The Blandin Foundation in Grand Rapids, Minn., is giving $20 million to the Itasca Medical Center for a new community health care campus in Grand Rapids.
* Stanford University will establish a new institute for the study of particle astrophysics and cosmology, thanks for a $15 million donation by Pehong Chen, founder and CEO of BroadVision, and his wife, Adele.
* Denso International America Inc. has established a corporate foundation and plans to build its assets to $15 million by 2010. Japan-based Denso, is the world’s fourth-largest automotive supplier.
* The Ewing Marion Kauffman Foundation is giving $9.66 million over five years – its second-largest grant ever – to the Kansas City, Kan., school district, The Kansas City Star reported March 9. For full story, go to The Kansas City Star.
* The Greater Bay Area Chapter of the Juvenile Diabetes Research Foundation raised $4.5 million for diabetes research through four local events in the Walk to Cure Diabetes. Of the total, the most raised by any chapters in the U.S. through a walk last year, $3.45 million was raised by the Silicon Valley Walk. That walk received a $2 million donation from venture capital firm Benchmark Capital — the largest gift to any of the walks throughout the U.S. All walks raised a total of $68 million in 2000.
* Hunters and conservations raised nearly $4 million during the 24th annual convention of the Foundation for North American Wild Sheep. More than $1.6 million of the total, raised through a special hunt-tag auction, will fund state and provincial wild sheep and wildlife programs.
* Breast-cancer research will get a boost, thanks to $2.5 million in funding to the Universite de Montreal and its Teaching Hospital. The funding includes an endowment of $1 million to create the Scotiabank chair in diagnosis and treatment of breast cancer; $1 million from Eli Lilly Canada to create a research fund; and $600,000 by the Teaching Hospital’s CHUM Foundation.
* MichCon and its MichCon Foundation donated $1.9 million in 2000 to nonprofits and charities in Michigan.
* Princeton University has received $1.9 million from The Pew Charitable Trusts to create a national data archive for policy and the arts — the first electronic archive in the U.S. devoted to research data on the arts and culture.
* A graduate of the University of Virginia has given $1.5 million to Monticello and the University of Virginia Library, the Associated Press reported March 14. The gift from Jeffrey C. Walker, a managing partner of J.P. Morgan Partners, the private equity fund of J.P. Morgan Chase & Co., will pay for technology for scholarship, research and library projects. For full story, go to dailypress.com.
* The American Foundation for AIDS Research has announced basic research grants of nearly $1.2 million for 13 projects to identify potential cellular and viral targets for the development of novel anti-HIV drugs.